Grantham, Mayo, Van Otterloo & Co (GMO)’s Erie Indemnity ERIE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-19,612
Closed -$4.36M – 731
2022
Q3
$4.36M Buy
+19,612
New +$4.13M 0.03% 345

Other funds holding ERIE

Grantham, Mayo, Van Otterloo & Co (GMO)'s ERIE Position: Q4 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Erie Indemnity (ERIE) in Q4 2022, closing a stake of 19,612 shares — an estimated $4.36M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ERIE in Q3 2022 and held it in 1 quarter. The position peaked at $4.36M in Q3 2022. 284 funds tracked by Wall St. Rank hold ERIE as of Q4 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Erie Indemnity position as of Q4 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 19,612 Erie Indemnity shares in Q4 2022, an estimated $4.36M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Erie Indemnity in Q3 2022 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Erie Indemnity position peaked at $4.36M in Q3 2022.
  • 284 funds tracked by Wall St. Rank held Erie Indemnity as of Q4 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2022, filed 13 Feb 2023.